North Carolina Administrative Code › Title 21 - OCCUPATIONAL LICENSING BOARDS AND COMMISSIONS › Chapter 32 - NORTH CAROLINA MEDICAL BOARD › Subchapter M - APPROVAL OF NURSE PRACTITIONERS › Section 32M .0109 - PRESCRIBING AUTHORITY

Current through Register Vol. 39, No. 2, July 15, 2024
(a) The prescribing
				stipulations contained in this Rule apply to writing prescriptions and ordering
				the administration of medications.
(b) Prescribing and dispensing stipulations
				are as follows:
(1) Drugs and devices that
				may be prescribed by the nurse practitioner in each practice site shall be
				included in the collaborative practice agreement as outlined in Rule .0110(2)
				of this Section.
(2) Controlled
				Substances (Schedules II, IIN, III, IIIN, IV, V) defined by the State and
				Federal Controlled Substances Acts may be procured, prescribed, or ordered as
				established in the collaborative practice agreement, providing all of the
				following requirements are met:
(A) the nurse
				practitioner has an assigned DEA number that is entered on each prescription
				for a controlled substance;
(B)
				refills may be issued consistent with Controlled Substance laws and
				regulations; and
(C) the primary
				supervising physician(s) shall possess a schedule(s) of controlled substances
				equal to or greater than the nurse practitioner's DEA registration.
(3) The nurse practitioner may
				prescribe a drug or device not included in the collaborative practice agreement
				only as follows:
(A) upon a specific written
				or verbal order obtained from a primary or back-up supervising physician before
				the prescription or order is issued by the nurse practitioner; and
(B) the written or verbal order as described
				in Part (b)(3)(A) of this Rule shall be entered into the patient record with a
				notation that it is issued on the specific order of a primary or back-up
				supervising physician and signed by the nurse practitioner and the
				physician.
(4) Each
				prescription shall be noted on the patient's chart and include the following
				information:
(A) medication and
				dosage;
(B) amount
				prescribed;
(C) directions for
				use;
(D) number of refills;
				and
(E) signature of nurse
				practitioner.
(5)
				Prescription Format:
(A) All prescriptions
				issued by the nurse practitioner shall contain the name of the patient and the
				nurse practitioner's name and telephone number;
(B) The nurse practitioner's assigned DEA
				number shall be written on the prescription form when a controlled substance is
				prescribed as defined in Subparagraph (b)(2) of this Rule.
(6) A nurse practitioner shall not prescribe
				controlled substances, as defined by the State and Federal Controlled
				Substances Acts, for the following:
(A) nurse
				practitioner's own use;
(B) nurse
				practitioner's supervising physician;
(C) a member of the nurse practitioner's
				immediate family, which shall mean a:
(i)
				spouse;
(ii) parent;
(iii) child;
(iv) sibling;
(v) parent-in-law;
(vi) son or daughter-in-law;
(vii) brother or sister-in-law;
(viii) step-parent;
(ix) step-child; or
(x) step-siblings;
(D) any other person living in the same
				residence as the licensee; or
(E)
				anyone with whom the nurse practitioner is having a physical, sexual, or
				emotionally intimate relationship.